Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
04/2010
04/20/2010US7700562 Use of —furin—“convertase” inhibitors in the treatment of fibrosis and scarring
04/20/2010US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides
04/20/2010US7700554 Compositions for modulating blood-brain barrier transport
04/20/2010US7700368 plant extracts; obtaining ethanolic solution, passing through column of activated charcoal, and collecting the eluate, removing solvent by rotary evaporation, redissolving in methanol, filtering
04/20/2010US7700304 inhibiting formation of neurofibrillary tangles by reducing formation of a carboxyl-terminal truncated form of apolipoprotein E (apoE) in a neuron in the individual; animal models of Alzheimer's disease (AD); treating AD; drug screening
04/20/2010US7700271 Method of diagnosis and treatment and agents useful for same
04/20/2010US7700122 Topical compositions comprising an opioid analgesic and an NMDA antagonist
04/20/2010US7700107 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits
04/20/2010US7700085 Administering an agent which inhibits binding of advanced glycation endproducts to any of their receptors; wound healing
04/20/2010CA2561950C 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
04/20/2010CA2448356C N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
04/20/2010CA2438506C Use of a cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications
04/20/2010CA2433915C Improved controlled release oral dosage form
04/20/2010CA2432178C Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles
04/20/2010CA2425338C Compositions comprising modafinil compounds
04/20/2010CA2419880C 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1h)one derivatives
04/20/2010CA2410579C Methods and compositions for treating flaviviruses and pestiviruses
04/20/2010CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use
04/20/2010CA2229078C Pharmaceutical composition containing il-10
04/20/2010CA2134756C Selectin variants
04/15/2010WO2010042886A2 Pyrone analogs for therapeutic treatment
04/15/2010WO2010042780A2 Methods and compositions for treating status epilepticus and seizures causing status epilepticus
04/15/2010WO2010042759A2 Gaba conjugates and methods of use thereof
04/15/2010WO2010042475A1 Spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
04/15/2010WO2010042030A1 Aspartyl protease inhibitors
04/15/2010WO2010041983A1 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof
04/15/2010WO2010041711A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient
04/15/2010WO2010041681A1 Novel sominone derivative
04/15/2010WO2010041405A1 Prophylactic/therapeutic agent for depression
04/15/2010WO2010041252A2 Use of a cinnamon bark extract for treating amyloid-associated diseases
04/15/2010WO2010041162A1 Tetrahydrofuranyl sulfonamides for use as ampa modulators in the treatment of cns disorders
04/15/2010WO2010041144A2 Beta-hydroxy-gamma-aminophosphonates and methods for the preparation and use thereof
04/15/2010WO2010040992A1 Quinoline derivatives having dp and / or crth2 receptor activity
04/15/2010WO2010040826A1 6-phenyl-pyrimidin-4-yl-(phenylamine or phenoxy) derivatives useful as modulators of nicotinic acetylcholine receptors
04/15/2010WO2010040808A1 Novel quinolinylamide derivatives useful as modulators of dopamine and serotonin receptors
04/15/2010WO2010040661A1 Modulators for amyloid beta
04/15/2010WO2010040315A1 The 1-butyl-2-hydroxyaralkyl piperazine derivatives and the uses as anti-depression medicine thereof
04/15/2010WO2010040274A1 Novel dopamine d3 receptor ligands, the preparation and use thereof
04/15/2010WO2010022249A3 Macrocyclic compounds for inhibition of tumor necrosis factor alpha
04/15/2010WO2010021680A3 Inhibitors of beta-secretase
04/15/2010WO2010018837A3 Protein cross-linking inhibitor
04/15/2010WO2010018836A3 Polyglutamine aggregation inhibitor
04/15/2010WO2010012817A3 5ht7 receptor ligands and compositions comprising the same
04/15/2010WO2010008513A3 Devices for the treatment of vascular aneurysm
04/15/2010WO2010005558A3 Pi3k isoform selective inhibitors
04/15/2010WO2010005310A3 Complement antagonists and uses thereof
04/15/2010WO2010002209A3 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist and pharmaceutical compositions containing the same
04/15/2010WO2009152347A3 Crystalline forms of zotepine hydrochloride
04/15/2010WO2009150040A3 Opiorphin for use as a psychostimulant agent
04/15/2010WO2009146218A3 Compounds including an anti-inflammatory pharmacore and methods of use
04/15/2010WO2009071753A8 4-phenyl-1,3-thiazole and 4-phenyl-1,3-oxazole derivatives as cannabinoid receptor ligands
04/15/2010WO2005074981A8 Inhibitors of tgf-r signaling for treatment of cns disorders
04/15/2010US20100095387 Methods and reagents for screening new drugs and for treating ion pump associated disorders and diseases
04/15/2010US20100093870 Herbal medicaments for the treatment of neurocerebrovascular disorders
04/15/2010US20100093853 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
04/15/2010US20100093848 Propargylated aminoindans, processes for preparation, and uses thereof
04/15/2010US20100093839 hypoxia-inducible factor-1 alpha (HIP-1 alpha); nucleosides, Locked Nucleic Acids; treating kidney cancer, melanoma, glioblastoma and prostate cancer, and pre-eclampsia
04/15/2010US20100093828 Compounds for the treatment of proliferative disorders
04/15/2010US20100093818 Benzimidazole derivatives
04/15/2010US20100093814 Novel compounds as cannabinoid receptor ligands and uses thereof
04/15/2010US20100093812 Desferrithiocin polyether analogues
04/15/2010US20100093810 Pharmaceutical Compositions for Reducing Amyloid Deposition, Amyloid Neurotoxicity, and Microgliosis
04/15/2010US20100093807 Substituted 7-azabicyclo[2.2.1]heptyl derivatives useful for making pharmaceutical compositions
04/15/2010US20100093806 Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs
04/15/2010US20100093805 Method of treating amblyopia
04/15/2010US20100093802 Ccr9 inhibitors and methods of use thereof
04/15/2010US20100093800 Apparatus, method and drug products for providing a conscious patient relief from pain and anxiety associated with medical or surgical procedures
04/15/2010US20100093797 Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate
04/15/2010US20100093793 Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
04/15/2010US20100093788 Heterocyclic benzimidazoles as trpm8 modulators
04/15/2010US20100093787 Treatment of impaired respiratory function with gaboxadol
04/15/2010US20100093774 5-substituted quinazolinone derivatives and compositions comprising and methods of using the same
04/15/2010US20100093769 Compounds
04/15/2010US20100093764 AMINES AND SULFOXIDES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
04/15/2010US20100093763 PHENYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINES AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
04/15/2010US20100093759 Bicyclic anilide heterocyclic cgrp receptor antagonists
04/15/2010US20100093756 HETEROARYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
04/15/2010US20100093745 Therapeutic agent or prophylactic agent for demyelinating disease comprising amino alcohol derivative as active ingredient
04/15/2010US20100093740 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives
04/15/2010US20100093723 HETEROCYCLYL AND CYCLOALKYL SUBSTITUTED THIENO[2,3 d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
04/15/2010US20100093722 HETEROARYL AND PHENYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINES AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
04/15/2010US20100093721 PHENYL AND HETEROARYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINES AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
04/15/2010US20100093714 AMIDES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
04/15/2010US20100093710 Galenical form for the administration of paracetamol by transmucous means
04/15/2010US20100093708 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
04/15/2010US20100093706 Multimediator transporter inhibitors for use in treatment of central nervous system disorders
04/15/2010US20100093704 Novel psychotropic agents having glutamate nmda activity
04/15/2010US20100093702 METHYLENE AMINES OF THIENO[2,3-d]PYRIMIDINE AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
04/15/2010US20100093700 Methods of Treating Mood Disorders
04/15/2010US20100093699 Compounds and uses thereof - 177
04/15/2010US20100093688 Porphyrin catalysts and methods of use thereof
04/15/2010US20100093687 Method Of Treating Disorder Related To High Cholesterol Concentration
04/15/2010US20100093672 Use of s1p receptor modulator
04/15/2010US20100093671 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
04/15/2010US20100093651 Artemisinin Derivatives
04/15/2010US20100093649 Synthetic glycolipid analogues and derivatives for the treatment of pathologic disorders
04/15/2010US20100093646 Method for enhancing memory in normal individual
04/15/2010US20100093641 Silk protein-mimicking peptides and compositions for preventing or treating cranial neuropathies comprising the same
04/15/2010US20100093632 Enamel matrix protein composition for treatment of systemic inflammatory response
04/15/2010US20100093602 Methods and compositions for modulating adhesion and migration of cadherin expressing cells
1 ... 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 ... 1833